Efficacy and safety of venetoclax in patients with relapsed/refractory multiple myeloma: a meta-analysis

被引：0
|
作者：
Xiaohui Gao
Hui Zeng
Xiaoyan Zhao
Haibing Wu
Minchao Yan
Yuan Li
Gang Zhang
Fei Sun
机构：
[1] The Affiliated Hospital of Jiaxing University,Departments of Pediatrics
[2] The Affiliated Hospital of Jiaxing University,Departments of Hematology
来源：
BMC Cancer | / 23卷
关键词：
Venetoclax; Multiple Myeloma; Efficacy; Adverse events; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of venetoclax in patients with relapsed/refractory multiple myeloma: a meta-analysis
    Gao, Xiaohui
    Zeng, Hui
    Zhao, Xiaoyan
    Wu, Haibing
    Yan, Minchao
    Li, Yuan
    Zhang, Gang
    Sun, Fei
    BMC CANCER, 2023, 23 (01)
  • [2] Safety and Efficacy of Venetoclax in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
    Durer, Ceren
    Durer, Seren
    Ijaz, Awais
    Kamal, Ahmad
    Abu Zar, Muhammad
    Rafae, Abdul
    Malik, Mustafa Nadeem
    Khan, Ali Younas
    Usman, Muhammad
    Selene, Insija Ilyas
    Tariq, Muhammad Junaid
    Fraz, Muhammad Asad
    Jose, Jemin Aby
    Anwer, Faiz
    BLOOD, 2018, 132
  • [3] Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis
    Shafei, Laila
    Bashir, Shaima
    Chan, Esther W.
    Abushanab, Dina
    Hamad, Anas
    Al-Badriyeh, Daoud
    CURRENT PROBLEMS IN CANCER, 2024, 50
  • [4] Efficacy and safety of selinexor for patients with relapsed and refractory multiple myeloma: A meta-analysis
    Al-Badriyeh, Daoud
    Shafei, Laila
    Bashir, Shaima
    Abushanab, Dina
    Hamad, Anas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 263 - 263
  • [5] EFFICACY AND SAFETY OF SELINEXOR FOR PATIENTS WITH RELAPSED AND REFRACTORY MULTIPLE MYELOMA: A META-ANALYSIS
    Abushanab, D.
    Mraiche, F.
    Al-Badriyeh, D.
    VALUE IN HEALTH, 2021, 24 : S22 - S22
  • [6] Efficacy of Venetoclax Based Regimens in Relapsed Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
    Hashim, Laila
    Faisal, Muhammad Salman
    Ahmed, Zahoor
    Selene, Insija Ilyas
    Shahzad, Moazzam
    Abdullah, Syed Maaz
    Samhouri, Yazan
    Yasir, Muhammad
    Wahab, Ahsan
    Ehsan, Hamid
    Neupane, Karun
    Anwer, Faiz
    Fazal, Salman
    BLOOD, 2020, 136
  • [7] Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients
    Botta, Cirino
    Ciliberto, Domenico
    Rossi, Marco
    Staropoli, Nicoletta
    Cuce, Maria
    Galeano, Teresa
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    BLOOD ADVANCES, 2017, 1 (07) : 455 - 466
  • [8] Efficacy and safety of venetoclax-based regimens for the treatment of relapsed/refractory multiple myeloma: a systemic review and meta-analysis
    Xu, Linchun
    Lin, Shaoze
    Xing, Xueyang
    Su, Yongzhong
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2023, 14
  • [9] Efficacy of thalidomide therapy in patients with relapsed or refractory multiple myeloma: a meta-analysis
    Vardhan, Gyan
    Kumar, Vikas
    Sherawat, Amit
    Singh, Neha
    Dhamija, Puneet
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S192 - S192
  • [10] Efficacy and Safety of Teclistamab in Relapsed or Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis
    Qureshi, Zaheer
    Jamil, Abdur
    Altaf, Faryal
    Siddique, Rimsha
    Faisal, Muhammad Salman
    Gupta, Sorab
    Berard, Paul Edward
    BLOOD, 2024, 144 : 7010 - 7011
12345